The study demonstrated that PRI-724 significantly reduces cell proliferation of different subtypes of STS cell lines in vitro by downregulating the expression of the WNT target gene CDC25A, which is highly expressed in STS patient samples, thereby inducing cell death or cycle arrest. The gene discussed is CDC25A; the disease is telomere syndrome.